Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
middle aged (6) 6
female (5) 5
male (5) 5
adult (4) 4
aged (4) 4
index medicus (4) 4
blood pressure - drug effects (3) 3
double-blind method (3) 3
follow-up studies (3) 3
hypertension (3) 3
hypertension - drug therapy (3) 3
hypertension - physiopathology (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
amlodipine (2) 2
antihypertensive agents - adverse effects (2) 2
antihypertensive agents - therapeutic use (2) 2
calcium channel blocker (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular (2) 2
cardiovascular events (2) 2
clinical trials (2) 2
comparative analysis (2) 2
coronary angiography (2) 2
coronary artery disease - diagnostic imaging (2) 2
dihydropyridines - adverse effects (2) 2
dihydropyridines - therapeutic use (2) 2
drug-eluting stents (2) 2
essential hypertension (2) 2
heart attacks (2) 2
immunosuppressive agents - pharmacology (2) 2
management (2) 2
pharmacology & pharmacy (2) 2
prospective studies (2) 2
prosthesis design (2) 2
sirolimus - pharmacology (2) 2
stent (2) 2
stents (2) 2
time factors (2) 2
2-year follow-up (1) 1
7th report (1) 1
acute coronary syndromes (1) 1
administration, oral (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
amlodipine - adverse effects (1) 1
amlodipine - therapeutic use (1) 1
analysis (1) 1
angiogenesis inhibitors (1) 1
angioplasty (1) 1
angioplasty, balloon, coronary (1) 1
angiotensin ii type 1 receptor blockers - therapeutic use (1) 1
anticoagulant (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulation (1) 1
antihypertensive agents - administration & dosage (1) 1
antihypertensive efficacy (1) 1
antihypertensive therapy (1) 1
antineoplastic agents (1) 1
antineoplastic agents, phytogenic - pharmacology (1) 1
antithrombotic therapy (1) 1
arteries (1) 1
asian continental ancestry group (1) 1
atherosclerosis (1) 1
atrial fibrillation - drug therapy (1) 1
atrial fibrillation - pathology (1) 1
barriers (1) 1
blood-pressure (1) 1
calcium channel blockers - therapeutic use (1) 1
calcium-antagonists (1) 1
calcium-channel blocker (1) 1
cardiology (1) 1
carotid-artery (1) 1
central aortic pressure (1) 1
central blood pressure (1) 1
central pulse pressure (1) 1
clinical outcomes (1) 1
combination (1) 1
coronary artery disease - mortality (1) 1
coronary artery disease - surgery (1) 1
coronary stenosis - diagnostic imaging (1) 1
coronary stenosis - surgery (1) 1
coronary vessels (1) 1
coronary-artery lesions (1) 1
definitions (1) 1
diabetes-mellitus (1) 1
disease (1) 1
dizziness - chemically induced (1) 1
dose-response relationship, drug (1) 1
double-blind (1) 1
drug combinations (1) 1
drug dosages (1) 1
drug therapy (1) 1
edoxaban (1) 1
electrocardiography (1) 1
end-point reduction (1) 1
everolimus (1) 1
factor xa - metabolism (1) 1
factor xa inhibitor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
by Lee, Joo Myung, MD, MPH and Park, Kyung Woo, MD, PhD and Han, Jung-Kyu, MD, PhD and Yang, Han-Mo, MD, PhD and Kang, Hyun-Jae, MD, PhD and Koo, Bon-Kwon, MD, PhD and Bae, Jang-Whan, MD, PhD and Woo, Sung-Il, MD, PhD and Park, Jin Sik, MD, PhD and Jin, Dong-Kyu, MD, PhD and Jeon, Dong Woon, MD, PhD and Oh, Seok Kyu, MD, PhD and Park, Jong-Seon, MD, PhD and Kim, Doo-Il, MD, PhD and Hyon, Min Su, MD, PhD and Jeon, Hui-Kyung, MD, PhD and Lim, Do-Sun, MD, PhD and Kim, Myeong-Gon, MD, PhD and Rha, Seung-Woon, MD, PhD and Her, Sung-Ho, MD,PhD and Hwang, Jin-Yong, MD, PhD and Kim, Sanghyun, MD, PhD and Choi, Young Jin, MD, PhD and Kang, Jin Ho, MD, PhD and Moon, Keon-Woong, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 9, pp. 1329 - 1338
Long-term outcomes are imperative to confirm safety of drug-eluting stents. There have been 2 randomized controlled trials comparing everolimus-eluting stents... 
Cardiovascular | DIABETES-MELLITUS | TRIAL | DEFINITIONS | PERCUTANEOUS CORONARY INTERVENTION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | DISEASE | 2-YEAR FOLLOW-UP | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Agents | Male | Treatment Outcome | Coronary Artery Disease - mortality | Prosthesis Design | Sirolimus - pharmacology | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Time Factors | Percutaneous Coronary Intervention - methods | Electrocardiography | Female | Registries | Republic of Korea - epidemiology | Everolimus | Immunosuppressive Agents - pharmacology | Analysis | Stent (Surgery) | Angiogenesis inhibitors | Heart attacks | Drug therapy | Stents | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial
by Na, Sang-Hoon, MD, PhD and Lee, Hae-Young, MD, PhD and Hong Baek, Sang, MD, PhD and Jeon, Hui-Kyung, MD, PhD and Kang, Jin-Ho, MD, PhD and Kim, Yoon-Nyun, MD, PhD and Park, Chang-Gyu, MD, PhD and Ryu, Jae-Kean, MD, PhD and Rhee, Moo-Yong, MD, PhD and Kim, Moo-Hyun, MD, PhD and Hong, Taek-Jong, MD, PhD and Choi, Dong-Ju, MD, PhD and Cho, Seong-Wook, MD, PhD and Cha, Dong-Hun, MD, PhD and Jeon, Eun-Seok, MD, PhD and Kim, Jae-Joong, MD, PhD and Shin, Joon-Han, MD, PhD and Park, Sung-Ha, MD, PhD and Lee, Seung-Hwan, MD, PhD and John, Sung-Hee, MD, PhD and Shin, Eun-Seok, MD, PhD and Kim, Nam-Ho, MD, PhD and Lee, Sung-Yun, MD, PhD and Kwan, Jun, MD, PhD and Jeong, Myung-Ho, MD, PhD and Kim, Sang-Wook, MD, PhD and Jeong, Jin-Ok, MD, PhD and Kim, Dong-Woon, MD, PhD and Lee, Nam-Ho, MD, PhD and Park, Woo-Jung, MD, PhD and Ahn, Jeong-Cheon, MD, PhD and Won, Kyung-Heon, MD, PhD and Uk Lee, Seung, MD, PhD and Cho, Jang-Hyun, MD, PhD and Kim, Soon-Kil, MD, PhD and Ahn, Taehoon, MD, PhD and Hong, Sukkeun, MD, PhD and Yoo, Sang-Yong, MD, PhD and Kim, Song-Yi, MD and Kim, Byung-Soo, MD, PhD and Juhn, Jae-Hyeon, PhD and Kim, Sun-Young, MS and Lee, Yu-Jeong, MS and Oh, Byung-Hee, MD, PhD
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 8, pp. 1726 - 1739
Abstract Purpose The objective of this study was to evaluate the efficacy and safety of the lercanidipine/valsartan combination compared with lercanidipine... 
Internal Medicine | Medical Education | valsartan | hypertension | lercanidipine | combination | MORTALITY | METAANALYSIS | MANAGEMENT | CARDIOVASCULAR EVENTS | PREVENTION | BLOOD-PRESSURE | AMLODIPINE | TOLERABILITY | PHARMACOLOGY & PHARMACY | OUTCOMES | Valsartan - administration & dosage | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Dihydropyridines - adverse effects | Dose-Response Relationship, Drug | Young Adult | Valsartan - therapeutic use | Adult | Female | Blood Pressure - drug effects | Essential Hypertension | Headache - chemically induced | Double-Blind Method | Dizziness - chemically induced | Valsartan - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Dihydropyridines - therapeutic use | Aged | Drug Combinations | Hypertension | Clinical trials | Medical colleges | Substance abuse treatment | Acute coronary syndromes | Drug dosages | Response rates
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: The comparison of Efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial
by Seo, Jae-Bin, MD and Kang, Si-Hyuck, MD and Hur, Seung-Ho, MD, PhD and Park, Kyung Woo, MD, PhD and Youn, Tae-Jin, MD, PhD and Park, Jong-Seon, MD, PhD and Yang, Han-Mo, MD, PhD and Lee, Hae-Young, MD, PhD and Kang, Hyun-Jae, MD, PhD and Koo, Bon-Kwon, MD, PhD and Bae, Jang-Ho, MD, PhD and Kim, Sang-Wook, MD, PhD and Moon, Keon-Woong, MD, PhD and Choi, Jae-Woong, MD, PhD and Lee, Sang-Gon, MD, PhD and Chung, Woo-Young, MD, PhD and Kim, Soo-Joong, MD, PhD and Kim, Doo-Il, MD, PhD and Kim, Byung-Ok, MD, PhD and Hyon, Min-Su, MD, PhD and Park, Keum-Soo, MD, PhD and Cha, Tae-Joon, MD, PhD and Yoo, Chul-Woong, MD, PhD and Jeon, Hui-Kyung, MD, PhD and Kim, Hyo-Soo, MD, PhD
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 5, pp. 733 - 743
Aims Paclitaxel-eluting stents (PESs) have been shown to inhibit neointimal hyperplasia after percutaneous coronary intervention. Coroflex Please (B Braun,... 
Cardiovascular | MIGRATION | SLOW-RELEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | STRUT THICKNESS | CORONARY-ARTERY LESIONS | SAFETY | MUSCLE-CELL PROLIFERATION | RESTENOSIS | Coronary Stenosis - diagnostic imaging | Drug-Eluting Stents | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Prosthesis Design | Sirolimus - pharmacology | Angioplasty, Balloon, Coronary | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Stenosis - surgery | Time Factors | Female | Antineoplastic Agents, Phytogenic - pharmacology | Immunosuppressive Agents - pharmacology | Comparative analysis | Stent (Surgery) | Paclitaxel | Heart attacks | Angioplasty | Stents | Stainless steel
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation
by N. Chung and H.-K. Jeon and L.-M. Lien and W.-T. Lai and H.-F. Tse and W.-S. Chung and T.-H. Lee and S.-A. Chen
Thrombosis and Haemostasis, ISSN 0340-6245, 03/2011, Volume 105, Issue 3, pp. 535 - 545
Edoxaban is an oral, reversible, direct factor Xa inhibitor in phase III clinical development for the prevention of stroke in atrial fibrillation (AF). A phase... 
anticoagulant | edoxaban | non-valvular atrial fibrillation | Factor Xa inhibitor | warfarin | New Technologies, Diagnostic Tools and Drugs | Warfarin | Anticoagulant | Edoxaban | Non-valvular atrial fibrillation | TRIALS | HOSPITALIZED-PATIENTS | RISK-FACTORS | MANAGEMENT | STROKE PREVENTION | BARRIERS | ANTICOAGULATION | PROPHYLAXIS | ANTITHROMBOTIC THERAPY | PERIPHERAL VASCULAR DISEASE | factor Xa inhibitor | HEMATOLOGY | WARFARIN USE | Atrial Fibrillation - pathology | Pyridines - administration & dosage | Anticoagulants - administration & dosage | Double-Blind Method | Factor Xa Inhibitors | Administration, Oral | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Thiazoles - administration & dosage | Hemorrhage | Warfarin - administration & dosage | Factor Xa - metabolism | Asian Continental Ancestry Group | Aged, 80 and over | Adult | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension
by Sang-Hyun Ihm Hui-Kyung Jeon Shung Chull Chae Do-Sun Lim Kee-Sik Kim Dong-Ju Choi Jong-Won Ha Dong-Soo Kim Kye Hun Kim Myeong-Chan Cho Sang Hong Baek and BELASCO Trial Investigators and BELASCO trial investigators, Republic of Korea
中华医学杂志：英文版, ISSN 0366-6999, 2013, Volume 126, Issue 11, pp. 2021 - 2028
Background Central blood pressure （BP） is pathophysiologically more important than peripheral BP for the pathogenesis of cardiovascular disease. Arterial... 
硬度 | 原发性高血压 | 中央 | 心血管疾病 | 高血压患者 | 动脉 | 类似 | 氯沙坦 | Hypertension | Central blood pressure | Stiffness | Calcium channel blocker | Arteries | CALCIUM-CHANNEL BLOCKER | CARDIOVASCULAR EVENTS | CAROTID-ARTERY | arteries | ATHEROSCLEROSIS | stiffness | CENTRAL AORTIC PRESSURE | RECEPTOR BLOCKER | MEDICINE, GENERAL & INTERNAL | END-POINT REDUCTION | central blood pressure | calcium channel blocker | DOUBLE-BLIND | hypertension | INTERVENTION | CENTRAL PULSE PRESSURE | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Hypertension - physiopathology | Dihydropyridines - adverse effects | Dihydropyridines - therapeutic use | Vascular Stiffness - drug effects | Adolescent | Losartan - therapeutic use | Losartan - adverse effects | Adult | Female | Aged | Blood Pressure - drug effects | Essential Hypertension
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial
by Hong, Soon Jun and Ahn, Tae-Noon and Baek, Sang-Hong and Cho, Wook-Hyun and Jeon, Hyee-Kyoung and Kyun, Jun and Yoon, Myeong Ho and Lee, Kwan Jeh and Lim, Do-Sun
Clinical Therapeutics, ISSN 0149-2918, 2006, Volume 28, Issue 4, pp. 537 - 551
The purpose of this study was to compare the efficacy and tolerability of amlodipine orotate with those of amlodipine besylate in Korean patients with mild to... 
antihypertensive therapy | orotate | hypertension | calcium channel blocker | amlodipine | UNITED-STATES | ANTIHYPERTENSIVE EFFICACY | KOREAN PATIENTS | CALCIUM-ANTAGONISTS | LEG EDEMA | JOINT NATIONAL COMMITTEE | NIFEDIPINE GITS | PHARMACOLOGY & PHARMACY | HIGH BLOOD-PRESSURE | URIC-ACID | 7TH REPORT | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Amlodipine - adverse effects | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Heart Rate - drug effects | Adult | Female | Aged | Blood Pressure - drug effects | Korea | Hypertension | Amlodipine | Clinical trials | Cardiology | Comparative analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.